These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29978322)

  • 21. The effects of defibrinogenation with batroxobin on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Furukawa Y; Takemura S; Kato H; Kondo M
    Thromb Res; 1983 Sep; 31(5):729-35. PubMed ID: 6359574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defibrinogenating enzymes.
    Bell WR
    Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tolerability and pharmacokinetics of TB-402 in healthy male volunteers.
    Verhamme P; Pakola S; Jensen TJ; Berggren K; Sonesson E; Saint-Remy JM; Balchen T; Belmans A; Cahillane G; Stassen JM; Peerlinck K; Glazer S; Jacquemin M
    Clin Ther; 2010 Jun; 32(6):1205-20. PubMed ID: 20637972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacology of intravenously administered recombinant desulfatohirudin (CGP 39393) in healthy volunteers.
    Marbet GA; Verstraete M; Kienast J; Graf P; Hoet B; Tsakiris DA; Silling-Engelhardt G; Close P
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):364-72. PubMed ID: 7504125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and Safety of Batroxobin, Tranexamic Acid and a Combination in Reduction of Blood Loss in Lumbar Spinal Fusion Surgery.
    Nagabhushan RM; Shetty AP; Dumpa SR; Subramanian B; Kanna RM; Shanmuganathan R
    Spine (Phila Pa 1976); 2018 Mar; 43(5):E267-E273. PubMed ID: 28678111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin.
    Vu TT; Stafford AR; Leslie BA; Kim PY; Fredenburgh JC; Weitz JI
    J Biol Chem; 2013 Jun; 288(23):16862-16871. PubMed ID: 23612970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemostyptic effects of batroxobin with regard to hirudin treatment.
    Markwardt F; Kaiser B; Richter M
    Thromb Res; 1992 Dec; 68(6):475-82. PubMed ID: 1341058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of batroxobin levels in the plasma of guinea pigs after epicutaneous and intravenous applications.
    Meier J; Adler C; Weiss N
    Toxicon; 1988; 26(10):964-6. PubMed ID: 3059582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation.
    Carr ME; Martin EJ; Carr SL
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):193-7. PubMed ID: 11943932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of Solulin, a novel recombinant soluble human thrombomodulin analogue.
    van Iersel T; Stroissnig H; Giesen P; Wemer J; Wilhelm-Ogunbiyi K
    Thromb Haemost; 2011 Feb; 105(2):302-12. PubMed ID: 21103657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lepirudin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen JB; Stohlawetz P; Eichler HG; Handler S; Speiser W; Jilma B
    Blood; 2000 Mar; 95(5):1729-34. PubMed ID: 10688831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic change of coagulation and anticoagulation markers of patients with acute cerebral infarction during intravenous urokinase thrombolysis.
    Ji X; Meng R; Zhou J; Ling F; Jia J
    Neurol Res; 2006 Jan; 28(1):46-9. PubMed ID: 16464362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.
    Stangier J; Rathgen K; Stähle H; Gansser D; Roth W
    Br J Clin Pharmacol; 2007 Sep; 64(3):292-303. PubMed ID: 17506785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study.
    Kreutz R; Persson PB; Kubitza D; Thelen K; Heitmeier S; Schwers S; Becka M; Hemmrich M
    J Thromb Haemost; 2017 Oct; 15(10):2017-2028. PubMed ID: 28805299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
    Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relations between the concentration of fibrinogen, thromboplastin time, thrombin time and reptilase time in patients treated with Arwin].
    Paar D; Klüken N
    Med Welt; 1975 Sep; 26(38):1700-1. PubMed ID: 1186461
    [No Abstract]   [Full Text] [Related]  

  • 37. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
    Eerenberg ES; Kamphuisen PW; Sijpkens MK; Meijers JC; Buller HR; Levi M
    Circulation; 2011 Oct; 124(14):1573-9. PubMed ID: 21900088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamic markers in the early clinical assessment of otamixaban, a direct factor Xa inhibitor.
    Paccaly A; Ozoux ML; Chu V; Simcox K; Marks V; Freyburger G; Sibille M; Shukla U
    Thromb Haemost; 2005 Dec; 94(6):1156-63. PubMed ID: 16411387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of apixaban anticoagulation by four-factor prothrombin complex concentrates in healthy subjects: a randomized three-period crossover study.
    Song Y; Wang Z; Perlstein I; Wang J; LaCreta F; Frost RJA; Frost C
    J Thromb Haemost; 2017 Nov; 15(11):2125-2137. PubMed ID: 28846831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reptilase time (RT).
    Karapetian H
    Methods Mol Biol; 2013; 992():273-7. PubMed ID: 23546720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.